沃森生物(300142.SZ):股東劉俊輝解除質押合計2625萬股
格隆匯 5 月 7日丨沃森生物(300142.SZ)公佈,公司於日前收到公司股東劉俊輝吿知,獲悉劉俊輝所持公司的部分股份於近日解除質押。
劉俊輝曾於2020年4月13日、4月15日分別將其所持有的525萬股、2100萬股公司股票質押給海通證券,質押期限分別自上述質押日起至質權人向中國證券登記結算有限責任公司辦理解除質押登記為止。(具體詳見公司分別於2020年4月16日、4月18日披露的2020-035號、2020-037號公吿)
2021年4月29日,劉俊輝與海通證券就上述質押的合計2625萬股股票辦理了解除質押手續。劉俊輝此次解除質押的股份佔公司股份總數的1.68%,佔其所持公司股份的34.80%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.